ARTICLE | Distillery Therapeutics
Targeting UHRF1 for KRAS-driven lung cancer
July 21, 2023 5:57 PM UTC
Inhibiting UHRF1, an E3 ubiquitin ligase that promotes DNA methylation and DNA repair, could help treat KRAS-driven lung cancer by increasing expression of tumor suppressor genes.
In 3D cultures of primary mouse KRAS-mutant, p53-deficient lung cancer cells, shRNA knockdown screens of KRAS upstream modulators, downstream effectors and interaction partners identified UHRF1 as essential for spheroid growth. ...
BCIQ Company Profiles